|
Burns - Pipeline Review, H1 2019 |
Mar 29 2019 |
93 |
Global |
$2,000.00 |
|
|
Gorlin Syndrome (Basal Cell Nevus Syndrome/ Nevoid Basal Cell Carcinoma Syndrome) - Pipeline Review, H1 2019 |
Mar 29 2019 |
135 |
Global |
$2,000.00 |
|
|
Ocular Hypertension - Pipeline Review, H1 2019 |
Mar 29 2019 |
131 |
Global |
$2,000.00 |
|
|
Becker Muscular Dystrophy - Pipeline Review, H1 2019 |
Mar 29 2019 |
61 |
Global |
$2,000.00 |
|
|
Cat Allergy - Pipeline Review, H1 2019 |
Mar 29 2019 |
29 |
Global |
$2,000.00 |
|
|
Alpha- Antitrypsin Deficiency - Pipeline Review, H1 2019 |
Mar 29 2019 |
89 |
Global |
$2,000.00 |
|
|
Influenza A Virus, H3N2 Subtype Infections - Pipeline Review, H1 2019 |
Mar 26 2019 |
142 |
Global |
$2,000.00 |
|
|
Cryptococcosis - Pipeline Review, H1 2019 |
Mar 26 2019 |
53 |
Global |
$2,000.00 |
|
|
Coccidioidomycosis - Pipeline Review, H1 2019 |
Mar 26 2019 |
54 |
Global |
$2,000.00 |
|
|
Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) - Pipeline Review, H1 2019 |
Mar 26 2019 |
90 |
Global |
$3,500.00 |
|
|
Bcl 2 Like Protein 1 (Apoptosis Regulator BclX or BCLX or BCL2L1) - Pipeline Review, H1 2019 |
Mar 26 2019 |
55 |
Global |
$3,500.00 |
|
|
72 kDa Type IV Collagenase (Matrix Metalloproteinase 2 or Gelatinase A or Neutrophil Gelatinase or 72 kDa Gelatinase or TBE 1 or MMP2 or EC 3.4.24.24) - Pipeline Review, H1 2019 |
Mar 26 2019 |
32 |
Global |
$3,500.00 |
|
|
Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Pipeline Review, H1 2019 |
Mar 26 2019 |
44 |
Global |
$3,500.00 |
|
|
Nuclear Receptor ROR Gamma (Nuclear Receptor RZR Gamma or Nuclear Receptor Subfamily 1 Group F Member 3 or RAR Related Orphan Receptor C or Retinoid Related Orphan Receptor Gamma or RORC) - Pipeline Review, H1 2019 |
Mar 26 2019 |
115 |
Global |
$3,500.00 |
|
|
Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) - Pipeline Review, H1 2019 |
Mar 26 2019 |
46 |
Global |
$3,500.00 |
|
|
Candidiasis - Pipeline Review, H1 2019 |
Mar 26 2019 |
174 |
Global |
$2,000.00 |
|
|
Severe Acute Respiratory Syndrome (SARS) - Pipeline Review, H1 2019 |
Mar 26 2019 |
52 |
Global |
$2,000.00 |
|
|
Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 (Bcl 2 Like Protein 3 or Bcl 2 Related Protein EAT/Mcl1 or BCL2L3 or MCL1) - Pipeline Review, H1 2019 |
Mar 26 2019 |
76 |
Global |
$3,500.00 |
|
|
Intercellular Adhesion Molecule 1 (Major Group Rhinovirus Receptor or CD54 or ICAM1) - Pipeline Review, H1 2019 |
Mar 26 2019 |
46 |
Global |
$3,500.00 |
|
|
Cathepsin K (Cathepsin O or Cathepsin O2 or Cathepsin X or CTSK or EC 3.4.22.38) - Pipeline Review, H1 2019 |
Mar 26 2019 |
44 |
Global |
$3,500.00 |
|
|
Tumor Necrosis Factor Receptor Superfamily Member 5 (B Cell Surface Antigen CD40 or Bp50 or CDw40 or CD40L Receptor or TNFRSF5 or CD40) - Pipeline Review, H1 2019 |
Mar 26 2019 |
97 |
Global |
$3,500.00 |
|
|
Peroxisome Proliferator Activated Receptor Delta (NUCI or Nuclear Hormone Receptor 1 or Nuclear Receptor Subfamily 1 Group C Member 2 or Peroxisome Proliferator Activated Receptor Beta or NR1C2 or PPARD) - Pipeline Review, H1 2019 |
Mar 26 2019 |
96 |
Global |
$3,500.00 |
|
|
Alcohol Addiction - Pipeline Review, H1 2019 |
Mar 18 2019 |
144 |
Global |
$2,000.00 |
|
|
Anthrax - Pipeline Review, H1 2019 |
Mar 18 2019 |
107 |
Global |
$2,000.00 |
|
|
Alopecia - Pipeline Review, H1 2019 |
Mar 18 2019 |
160 |
Global |
$2,000.00 |
|
|
Prader-Willi Syndrome (PWS) - Pipeline Review, H1 2019 |
Mar 18 2019 |
105 |
Global |
$2,000.00 |
|
|
Bacillary Dysentery (Shigellosis) - Pipeline Review, H1 2019 |
Mar 18 2019 |
54 |
Global |
$2,000.00 |
|
|
Pulmonary Arterial Hypertension - Pipeline Review, H1 2019 |
Mar 18 2019 |
304 |
Global |
$2,000.00 |
|
|
Genital Herpes - Pipeline Review, H1 2019 |
Mar 18 2019 |
92 |
Global |
$2,000.00 |
|
|
Myocarditis - Pipeline Review, H1 2019 |
Mar 18 2019 |
37 |
Global |
$2,000.00 |
|
